13F 申报指南13F 概念全攻略
什么是 SEC Form 13F 申报？美股机构大户持股全攻略
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
AlphaSMO 权威研究指南阅读专题
CIK: 0001599882
申报总市值
US$10.6亿
US$10.6亿
90 檔
14.4%
在 Q2 2025 的 13F 官方备案中，Rhenman & Partners Asset Management AB 管理的美股投资组合规模来到 US$10.6亿，整体持股档数为 90 档。
在 Q2 2025，Rhenman & Partners Asset Management AB 展现出较为审慎的避险与获利了结姿态。本季共减仓 37 个仓位并完全清仓 15 档持股，调降曝光的仓位数量高于加仓动作。
在资产配置集中度方面，Rhenman & Partners Asset Management AB 的前 5 大核心持股（包含 LLY, BSX, VRTX 等）合计占整体申报市值的 14.4%，反映机构在主要关键仓位上的权重分布。
| # | 代码 | 标的名称 | 资产子类别 | 占比 | 占比变动 | 持仓量变化 | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly & Co | 股票-医疗保健 | 5.70% | -1.30% | +38.61% | |
| 2 | BSX | Boston Scientific CORP | 股票-医疗保健 | 4.02% | -3.03% | -1.33% | |
| 3 | VRTX | Vertex Pharmaceuticals Inc | 股票-医疗保健 | 3.46% | -0.96% | -7.93% | |
| 4 | GKOS | Glaukos CORP | 股票-医疗保健 | 3.07% | +0.45% | -12.96% | |
| 5 | ISRG | Intuitive Surgical Inc | 股票-医疗保健 | 3.05% | -0.80% | -13.88% | |
| 6 | THC | Tenet Healthcare CORP | 股票-医疗保健 | 3.04% | +0.24% | +7.68% | |
| 7 | DHR | Danaher CORP | 股票-医疗保健 | 3.03% | +1.02% | +189.50% | |
| 8 | CVS | Cvs Health CORP | 股票-医疗保健 | 2.58% | -0.25% | +25.23% | |
| 9 | MCK | Mckesson CORP | 股票-医疗保健 | 2.57% | -0.62% | -41.30% | |
| 10 | NBIX | Neurocrine Biosciences Inc | 股票-医疗保健 | 2.37% | -0.27% | +66.13% | |
| 11 | GILD | Gilead Sciences Inc | 股票-医疗保健 | 2.36% | -0.75% | -27.99% | |
| 12 | EXK | Exact Sciences CORP | 股票-原材料 | 2.35% | — | -20.45% | |
| 13 | ALHC | Alignment Healthcare Inc | 股票-其他 | 2.28% | -0.05% | -3.74% | |
| 14 | INSM | Insmed Inc | 股票-医疗保健 | 2.23% | -1.69% | -5.43% | |
| 15 | ELV | Elevance Health Inc | 股票-医疗保健 | 2.20% | +0.10% | -8.78% | |
| 16 | EHC | Encompass Health CORP | 股票-医疗保健 | 2.11% | +0.04% | +264.71% | |
| 17 | ALNY | Alnylam Pharmaceuticals Inc | 股票-医疗保健 | 2.11% | -0.92% | +6.22% | |
| 18 | MDT | Medtronic plc | 股票-医疗保健 | 1.98% | +0.11% | -29.61% | |
| 19 | COR | Cencora Inc | 股票-医疗保健 | 1.87% | -0.78% | +52.51% | |
| 20 | REGN | Regeneron Pharmaceuticals | 股票-医疗保健 | 1.84% | -2.98% | -12.76% | |
| 21 | PODD | Insulet CORP | 股票-医疗保健 | 1.83% | +0.24% | -24.59% | |
| 22 | DXCM | Dexcom Inc | 股票-医疗保健 | 1.76% | +1.02% | NEW | |
| 23 | ABBV | Abbvie Inc | 股票-医疗保健 | 1.63% | +0.38% | -21.74% | |
| 24 | ALGN | Align Technology Inc | 股票-医疗保健 | 1.59% | +0.84% | +60.24% | |
| 25 | RPRX | Royalty Pharma plc | 股票-医疗保健 | 1.57% | -0.34% | -16.30% | |
| 26 | COO | Cooper Cos Inc/the | 股票-医疗保健 | 1.53% | -0.07% | -27.97% | |
| 27 | JAZZ | Jazz Pharmaceuticals plc | 股票-医疗保健 | 1.46% | +0.22% | -12.28% | |
| 28 | HCA | Hca Healthcare Inc | 股票-医疗保健 | 1.44% | — | +77.48% | |
| 29 | PRCT | Procept Biorobotics CORP | 股票-其他 | 1.38% | -0.73% | -57.59% | |
| 30 | CI | THE Cigna Group | 股票-医疗保健 | 1.34% | +0.19% | +13.48% | |
| 31 | AKRO | Akero Therapeutics Inc | 股票-其他 | 1.33% | — | +113.62% | |
| 32 | VRNA | Verona Pharma PLC - Adr | 股票-其他 | 1.27% | — | +52.14% | |
| 33 | NTRA | Natera Inc | 股票-医疗保健 | 1.23% | +0.29% | -58.48% | |
| 34 | UNH | Unitedhealth Group Inc | 股票-医疗保健 | 1.20% | +2.15% | -60.70% | |
| 35 | AXSM | Axsome Therapeutics Inc | 股票-医疗保健 | 1.20% | +0.13% | -17.15% | |
| 36 | CAH | Cardinal Health Inc | 股票-医疗保健 | 1.17% | -0.20% | — | |
| 37 | BMRN | Biomarin Pharmaceutical Inc | 股票-医疗保健 | 1.04% | +0.13% | -43.53% | |
| 38 | ABT | Abbott Laboratories | 股票-医疗保健 | 1.01% | -0.60% | +12.50% | |
| 39 | IONS | Ionis Pharmaceuticals Inc | 股票-医疗保健 | 0.91% | -0.41% | +124.69% | |
| 40 | OSCR | Oscar Health Inc - Class A | 股票-医疗保健 | 0.85% | +0.13% | -69.48% | |
| 41 | MOH | Molina Healthcare Inc | 股票-医疗保健 | 0.84% | +0.47% | NEW | |
| 42 | ✓ | Merus N V | 股票-其他 | 0.77% | — | +55.70% | |
| 43 | ALC | Alcon Inc. | 股票-医疗保健 | 0.76% | — | — | |
| 44 | DVAX | Dynavax Technologies CORP | 股票-其他 | 0.71% | — | — | |
| 45 | PEN | Penumbra Inc | 股票-医疗保健 | 0.70% | — | +877.27% | |
| 46 | CNC | Centene CORP | 股票-医疗保健 | 0.68% | +1.48% | NEW | |
| 47 | SNDX | Syndax Pharmaceuticals Inc | 股票-其他 | 0.68% | +0.07% | +32.56% | |
| 48 | BRKR | Bruker CORP | 股票-医疗保健 | 0.64% | — | +191.42% | |
| 49 | AVR | Anteris Technologies Global | 股票-其他 | 0.60% | +0.44% | -3.04% | |
| 50 | ASTH | Astrana Health Inc | 股票-其他 | 0.60% | +0.52% | NEW |
| # | 代码 | 标的名称 | 占比变动 | 持仓量变化 | 异动类型 |
|---|---|---|---|---|---|
| 1 | DHR | Danaher CORP | +2% | +189.50% | 加仓 |
| 2 | LLY | Eli Lilly & Co | +1.7% | +38.61% | 加仓 |
| 3 | EHC | Encompass Health CORP | +1.7% | +264.71% | 加仓 |
| 4 | NBIX | Neurocrine Biosciences Inc | +1.2% | +66.13% | 加仓 |
| 5 | CAH | Cardinal Health Inc | +1.2% | NEW | 新建仓 |
| 6 | THC | Tenet Healthcare CORP | +1.1% | +7.68% | 加仓 |
| 7 | AKRO | Akero Therapeutics Inc | +0.9% | +113.62% | 加仓 |
| 8 | COR | Cencora Inc | +0.8% | +52.51% | 加仓 |
| 9 | ALGN | Align Technology Inc | +0.8% | +60.24% | 加仓 |
| 10 | HCA | Hca Healthcare Inc | +0.8% | +77.48% | 加仓 |
| 11 | ALC | Alcon Inc. | +0.8% | NEW | 新建仓 |
| 12 | VRNA | Verona Pharma PLC - Adr | +0.8% | +52.14% | 加仓 |
| 13 | CVS | Cvs Health CORP | +0.7% | +25.23% | 加仓 |
| 14 | PEN | Penumbra Inc | +0.6% | +877.27% | 加仓 |
| 15 | IONS | Ionis Pharmaceuticals Inc | +0.6% | +124.69% | 加仓 |
| 16 | ALNY | Alnylam Pharmaceuticals Inc | +0.6% | +6.22% | 加仓 |
| 17 | UHS | Universal Health Services-b | +0.6% | NEW | 新建仓 |
| 18 | INSM | Insmed Inc | +0.6% | -5.43% | 减仓 |
| 19 | SYK | Stryker CORP | +0.6% | NEW | 新建仓 |
| 20 | EW | Edwards Lifesciences CORP | +0.5% | NEW | 新建仓 |
| 21 | DXCM | Dexcom Inc | +0.5% | +2.90% | 加仓 |
| 22 | BSX | Boston Scientific CORP | +0.5% | -1.33% | 减仓 |
| 23 | BRKR | Bruker CORP | +0.4% | +191.42% | 加仓 |
| 24 | ✓ | Merus N V | +0.4% | +55.70% | 加仓 |
| 25 | RDNT | Radnet Inc | +0.3% | NEW | 新建仓 |
| 26 | VCEL | Vericel CORP | +0.3% | NEW | 新建仓 |
| 27 | LIVN | LivaNova PLC | +0.3% | NEW | 新建仓 |
| 28 | CI | THE Cigna Group | +0.3% | +13.48% | 加仓 |
| 29 | RGEN | Repligen CORP | +0.2% | +333.33% | 加仓 |
| 30 | ACLXGBX | Arcellx Inc | +0.2% | +54.60% | 加仓 |
| 31 | ABT | Abbott Laboratories | +0.2% | +12.50% | 加仓 |
| 32 | SMMT | Summit Therapeutics Inc | +0.2% | NEW | 新建仓 |
| 33 | GPCR | Structure Therapeutics Inc | +0.2% | +93.00% | 加仓 |
| 34 | INSP | Inspire Medical Systems Inc | +0.2% | +90.63% | 加仓 |
| 35 | DOCS | Doximity Inc-class A | +0.2% | NEW | 新建仓 |
| 36 | EXK | Exact Sciences CORP | +0.2% | -20.45% | 减仓 |
| 37 | APLSUSD | Apellis Pharmaceuticals Inc | +0.1% | +230.09% | 加仓 |
| 38 | ISRG | Intuitive Surgical Inc | +0.1% | -13.88% | 减仓 |
| 39 | BNTX | Biontech Se-adr | +0.1% | +0.34% | 加仓 |
| 40 | TECH | Bio-techne CORP | +0.1% | NEW | 新建仓 |
| 41 | RPRX | Royalty Pharma plc | +0.1% | -16.30% | 减仓 |
| 42 | RARE | Ultragenyx Pharmaceutical In | +0.1% | +13.54% | 加仓 |
| 43 | NUVL | Nuvalent Inc-a | +0.1% | — | 不变 |
| 44 | MLTX | Moonlake Immunotherapeutics | +0.1% | — | 不变 |
| 45 | ASTH | Astrana Health Inc | +0.1% | +26.67% | 加仓 |
| 46 | SNDX | Syndax Pharmaceuticals Inc | +0.1% | +32.56% | 加仓 |
| 47 | RLAY | Relay Therapeutics Inc | +0.1% | — | 不变 |
| 48 | AVR | Anteris Technologies Global | +0.1% | -3.04% | 减仓 |
| 49 | ANNX | Annexon Inc | 0% | — | 不变 |
| 50 | DNTH | Dianthus Therapeutics Inc | 0% | — | 不变 |
根据 SEC 官方 Form 13F 申报备案，Rhenman & Partners Asset Management AB 在 Q2 2025 季度的美股持仓总市值约为 US$10.6亿，共申报了 90 个公开持股仓位。
在 Q2 2025 季度，Rhenman & Partners Asset Management AB 按市值排列的前三大核心持股分别为：LLY (5.7%)、BSX (4.0%)、VRTX (3.5%)。其中最大持股仓位 LLY 占据整体投资组合约 5.7% 的权重。
精选 AlphaSMO 大户持股与内部人交易深度分析，提升投资决策胜率
完整解读 Form 13F 申报规范、1 亿美元门槛与 45 天延迟申报机制，学会如何追踪顶级对冲基金与机构法人持仓动向。
本季最大新建仓标的
CAH
市值: US$924.0万
本季最大获利了结 / 清仓标的
BMY
前期市值: US$1982.2万
在 Q2 2025 季度中，Rhenman & Partners Asset Management AB 共进行了 92 项持仓异动，包含新建仓 11 个仓位、加仓 29 个仓位、减仓 37 个仓位以及清仓 15 个仓位。 其中最大新建仓标的为 CAH。 本季清仓仓位包含 BMY。
本页面所有持股数据均直接同步自美国证券交易委员会（SEC）EDGAR 官方系统之 13F-HR / 13F-HR/A 季度申报文件。AlphaSMO 通过机器解析 CUSIP 与个股对照，提供 100% 精准对齐的历史时序数据集，并支持 Schema.org 结构化数据格式。
解析公司高管、董事与 10% 大股东之 Form 4 内部人交易申报，掌握高管自家股票买卖第一手信号。
深入剖析 5% 股权申报门槛、13D 与 13G 之差异，以及最新 SEC 申报时程规范，洞察机构法人的激进投资动向。